Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Pharma ADMET Testing Market?
The market size of pharma admet testing has experienced a swift expansion in the past few years. Predictions show that it will rise from a value of $9.67 billion in 2024 to an impressive $10.7 billion in 2025 with a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this growth in the historic period include an increase in biopharmaceuticals and biosimilars, elevated activities in drug development, a surge in awareness about drug safety, the global expansion of clinical trials, and a transition towards in silico modeling.
Expectations are high for the pharma admet testing market as it is set on a path of swift expansion in the coming years. Forecasts project it to escalate to a market size of $17.03 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.3%. Contributing factors for this growth during the forecast period can be traced to environmental toxicology and safety assessment, a heightened awareness of pharmacogenomics, a shift towards precision medicine, an upsurge in biologics and biosimilars, the incorporation of artificial intelligence (AI), augmented regulatory mandates, and a surge in orphan drug development. The forecast period also reveals several emerging trends including the upscaling of research collaborations, swift progress in technology, advances in analytical technologies, perpetual monitoring of drug safety, and consideration of environmental impacts.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp
What Are The Primary Factors Supporting The Pharma ADMET Testing Market Expansion?
The increase in product approval numbers is propelling the pharmaceutical ADMET testing market forward. This pertains to the procedures carried out by regulatory bodies like the United States’ Food and Drug Administration (FDA) or Europe’s European Medicines Agency (EMA), which provide clearance for a product to be sold and marketed to consumers. ADMET testing plays a critical role in assessing the safety and effectiveness of new products and is a compulsory requirement in attaining product regulatory clearances. For instance, figures from the National Library of Medicine, a US-based biomedical information resource for healthcare professionals, showed that there were 55 new drugs given the green light by the FDA in 2023, a significant increase from the 37 approved in 2022. Consequently, this heightened rate of product approvals fuels the growth of the pharmaceutical ADMET testing market.
Which Segments Define The Structure Of The Pharma ADMET Testing Market?
The pharma admet testingmarket covered in this report is segmented –
1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing
2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology
3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications
Subsegments:
1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling
What Strategic Shifts And Innovations Are Influencing The Pharma ADMET Testing Market?
Product innovation is emerging as a pivotal trend in the pharmaceutical ADMET testing market, with leading companies launching groundbreaking products to consolidate their market standing. For instance, Logica, a pioneering AI-driven drug development solution, was launched in April 2022 by Charles River Laboratories International Inc., an American pharmaceutical firm, and Valo Health Inc., a US-based AI-health solution provider. The novel product harnesses the power of Valo’s AI-enabled Opal Computational Platform to render ADMET testing services and various drug delivery solutions. Logica employs top-tier predictive models, chemical synthesis and design, DNA coded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. It also capitalizes on Charles River’s top-notch abilities in every facet of discovery optimization, including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and safety testing, culminating in IND submission.
Who Are The Primary Market Leaders In The Pharma ADMET Testing Market?
Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report
What Regional Factors Are Accelerating Growth In The Pharma ADMET Testing Market?
Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12024&type=smp
Browse Through More Reports Similar to the Global Pharma ADMET Testing Market 2025, By The Business Research Company
Healthcare Analytical Testing Services Global Market Report 2025
Automotive Testing Inspection And Certification Global Market Report 2025
Cold Plasma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model